No Data
UK's NHS Prescribes Weight-Loss Drug Wegovy Less Than Expected Due To Service Shortages
Express News | Eli Lilly and Novo Nordisk Shares Are Trading Lower After Competitor Viking Announced the Advancement of Its Obesity Candidate
The “up-and-coming diet drug” Viking (VKTX.US) drug enters the late stages of development, and the “Nolie” stock price fell in shock
As the Viking diet pill entered the later stages of clinical trials, Eli Lilly and Novo Nordisk stock prices declined.
Viking Sends Lilly, Novo Lower as Obesity Drug Enters Late-stage Program
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
Novo Nordisk's (NVO.US) weight-loss drug, Wegovy, has been approved by UK regulatory authorities and can be used to treat heart disease.
Following the United States, the regulatory authority in the United Kingdom has also approved the expansion of the application scope of Novo Nordisk's (NVO.US) weight loss drug Wegovy to treat heart disease.
No Data
